Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability (Q39689315)
Jump to navigation
Jump to search
scientific article published on 22 June 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability |
scientific article published on 22 June 2010 |
Statements
1 reference
Sensitivity of cancer cells to Plk1 inhibitor GSK461364A is associated with loss of p53 function and chromosome instability (English)
1 reference
Richard Wooster
1 reference
Junping Jing
1 reference
Joel Greshock
1 reference
Aidan G Gilmartin
1 reference
Xiping Zhang
1 reference
Christopher Moy
1 reference
Sylvie Laquerre
1 reference
Yan Degenhardt
1 reference
Mark Richter
1 reference
Maureen Bleam
1 reference
Wendy Halsey
1 reference
Ashley Hughes
1 reference
Nancy Liu-Sullivan
1 reference
Scott Powers
1 reference
Jeffrey Jackson
1 reference
Barbara Weber
1 reference
22 June 2010
1 reference
1 reference
9
1 reference
7
1 reference
2079-2089
1 reference
Identifiers
1 reference
1 reference